Opportunities and challenges for innovative and equitable healthcare
David J. Ecker(Harvard University), Michael R. Hayden(University of British Columbia), Barry Canton(Ginkgo Bioworks, Inc. (United States)), C. Simone Fishburn, Yesim Tozan, Janice S. Chen(Mammoth Biosciences (United States)), Melinda Kliegman(Innovative Genomics Institute), Xuanhe Zhao(East China Normal University), Fyodor D. Urnov(Innovative Genomics Institute), Kevin J. Tracey(Northwell Health), Shawneequa Callier(George Washington University), Joseph R. Arron(Rockefeller University), Amy Bernard(The Wistar Institute), Xandra O. Breakefield(Harvard University), Daniel J Wattendorf(Gates Foundation), Tobias Janowitz(Northwell Health), Christopher R. Lowe(Unknown), Clarice D. Aiello(University of California, Los Angeles), C. Frank Bennett(Pennsylvania State University), Thomas W. Williams, Banning Garrett, Timothy J. Broderick(Florida Institute for Human and Machine Cognition), Chrystal U. Louis, Alfica Sehgal(Alnylam Pharmaceuticals (United States)), Adrian R. Krainer(Cold Spring Harbor Laboratory), Sidney M. Hecht(University of Virginia)
Cited by 8
Related Papers
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
|Science|2018|4.4k
CRISPR–Cas12-based detection of SARS-CoV-2
|Nature Biotechnology|2020|2.8k
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
Hydrogel bioelectronics
|Chemical Society Reviews|2018|2k
New Technologies for Analysis of Extracellular Vesicles
|Chemical Reviews|2018|1.7k